Golden Cross Stocks — Financial View · Pharmaceutical Preparations
16 stocks match the Golden Cross Stocks screen. Stocks whose 50-day moving average has just crossed above their 200-day — a classic bullish trend signal. Financial columns. Filtered to Pharmaceutical Preparations. Updated
Filters2
1–16 of 16
| ONC | Beone Medicines Ltd. | $535.9B | — | 7.1% | 12.7% | 11.0% | 3.40 | 0.15 | 88.9% | 15.1% | 10.7% | 362.54 | +0.23% | 14K |
| REGN | Regeneron Pharmaceuticals | $87.2B | 0.4% | 10.4% | 13.7% | 12.8% | 3.34 | 0.06 | — | 24.7% | 27.9% | 843.50 | -1.02% | 28K |
| ZYME | Zymeworks Inc. | $2.1B | — | -37.8% | — | — | 6.32 | 3.94 | — | — | — | 29.89 | -3.70% | 26K |
| HROW | Harrow, Inc. | $1.4B | — | -8.9% | — | -11.8% | 2.24 | 19.74 | 73.3% | -1.0% | -13.5% | 38.28 | -1.86% | 22K |
| JANX | Janux Therapeutics, Inc. | $1.2B | — | -10.2% | -11.1% | -11.1% | 16.35 | 0.09 | — | — | — | 19.83 | +0.71% | 72K |
| GERN | Geron Corp | $967M | — | -13.0% | -30.9% | -20.0% | 6.92 | 0.55 | — | — | — | 1.50 | -5.35% | 1.3M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $442M | — | -41.6% | -54.3% | -49.9% | 5.88 | 0.09 | — | — | — | 15.56 | -7.07% | 41K |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $222M | — | -80.2% | -99.7% | -99.7% | 5.71 | 0.00 | — | — | — | 11.46 | -0.22% | 29K |
| LGVN | Longeveron Inc. | $186M | — | — | — | — | 2.63 | 0.01 | 69.8% | — | — | 6.61 | -3.22% | 973 |
| BMEA | Biomea Fusion, Inc. | $138M | — | -88.2% | — | — | 3.47 | 2.04 | — | — | — | 1.91 | -1.04% | 35K |
| ANIX | Anixa Biosciences Inc | $106M | — | -68.9% | -71.7% | — | 8.54 | 0.03 | — | — | — | 3.04 | -2.88% | 4K |
| CDT | CDT Equity Inc. | $550669 | — | -29.3% | -36.0% | -36.0% | 0.13 | 0.23 | — | — | — | 0.70 | -23.73% | 10K |
| CMMB | Chemomab Therapeutics Ltd. | — | — | -65.1% | -72.9% | — | 9.08 | 0.12 | — | — | — | 2.82 | +3.30% | 3K |
| GLMD | Galmed Pharmaceuticals Ltd. | — | — | -55.3% | -65.3% | — | 6.55 | 0.00 | — | — | — | 4.01 | -1.72% | 229 |
| PRQR | ProQR Therapeutics N.V. | — | — | — | — | — | — | — | — | — | — | 2.08 | -3.48% | 43K |
| GMAB | Genmab A/S | — | — | — | — | — | — | — | — | — | — | 34.41 | +0.56% | 66K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.